Cargando…
Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
BACKGROUND: End-stage renal failure occurs in a substantial number of patients having received a nonrenal transplantation (NRT), for whom a kidney transplantation is needed. The medical strategy regarding the use of immunosuppression (IS) for a kidney graft in patients after an NRT is not well estab...
Autores principales: | Mai, Hoa Le, Treilhaud, Michèle, Ben-Arye, Shani Leviatan, Yu, Hai, Perreault, Hélène, Ang, Evelyn, Trébern-Launay, Katy, Laurent, Julie, Malard-Castagnet, Stéphanie, Cesbron, Anne, Nguyen, Thi Van Ha, Brouard, Sophie, Rostaing, Lionel, Houssel-Debry, Pauline, Legendre, Christophe, Girerd, Sophie, Kessler, Michèle, Morelon, Emmanuel, Sicard, Antoine, Garrigue, Valérie, Karam, Georges, Chen, Xi, Giral, Magali, Padler-Karavani, Vered, Soulillou, Jean Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908458/ https://www.ncbi.nlm.nih.gov/pubmed/29707628 http://dx.doi.org/10.1097/TXD.0000000000000772 |
Ejemplares similares
-
Poor Long-Term Outcome in Second Kidney Transplantation: A Delayed Event
por: Trébern-Launay, Katy, et al.
Publicado: (2012) -
Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation
por: Mottola, Clément, et al.
Publicado: (2020) -
Editorial: Human Antibodies Against the Dietary Non-human Neu5Gc-Carrying Glycans in Normal and Pathologic States
por: Soulillou, Jean-Paul, et al.
Publicado: (2020) -
Discovery of rare sulfated N-unsubstituted glucosamine based heparan sulfate analogs selectively activating chemokines
por: Jain, Prashant, et al.
Publicado: (2021) -
Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy
por: Amon, Ron, et al.
Publicado: (2017)